Selected research
Market Outlook & Growth Opportunities
Global Alternative Medicines and Therapy Market Outlook and Growth Opportunities 2026
Market perspective
The global Alternative Medicines and Therapy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Alternative Medicines and Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Alternative Medicines and Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Alternative Medicines and Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Alternative Medicines and Therapy market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Alternative Medicines and Therapy market include Allen Laboratories Ltd., Arya Vaidya Pharmacy, Dr. Reddy’s Laboratories Ltd, King Bio Pharmaceuticals, Mediral International, Sandoz International GmbH, Biocon Ltd., Sante Verte Ltd., Weleda Ltd., Cipla Ltd. and Wright Health Group Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Alternative Medicines and Therapy market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Alternative Medicines and Therapy and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Alternative Medicines and Therapy revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Alternative Medicines and Therapy market.
Alternative Medicines and Therapy Segment by Company
Allen Laboratories Ltd.
Arya Vaidya Pharmacy
Dr. Reddy’s Laboratories Ltd
King Bio Pharmaceuticals
Mediral International
Sandoz International GmbH, Biocon Ltd.
Sante Verte Ltd.
Weleda Ltd., Cipla Ltd.
Wright Health Group Ltd.
Alternative Medicines and Therapy Segment by Type
Oil Massage Therapy
Mud Therapy
Magnetic Therapy
Alternative Medicines and Therapy Segment by Application
Hospital
Clinic
Alternative Medicines and Therapy Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Alternative Medicines and Therapy status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Alternative Medicines and Therapy key companies, revenue, market share, and recent developments.
3. To split the Alternative Medicines and Therapy breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Alternative Medicines and Therapy market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Alternative Medicines and Therapy significant trends, drivers, influence factors in global and regions.
6. To analyze Alternative Medicines and Therapy competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alternative Medicines and Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Alternative Medicines and Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alternative Medicines and Therapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Alternative Medicines and Therapy industry.
Chapter 3: Detailed analysis of Alternative Medicines and Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Alternative Medicines and Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Alternative Medicines and Therapy in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
List of Tables
Table 1. Alternative Medicines and Therapy Industry Trends
Table 2. Alternative Medicines and Therapy Industry Drivers
Table 3. Alternative Medicines and Therapy Industry Opportunities and Challenges
Table 4. Alternative Medicines and Therapy Industry Restraints
Table 5. Global Alternative Medicines and Therapy Revenue by Company (US$ Million) & (2021-2026)
Table 6. Global Alternative Medicines and Therapy Revenue Share by Company (2021-2026)
Table 7. Global Alternative Medicines and Therapy Company Ranking, (2024-2026) & (US$ Million)
Table 8. Global Alternative Medicines and Therapy Key Company Manufacturing Base & Headquarters
Table 9. Global Alternative Medicines and Therapy Company, Product Type & Application
Table 10. Global Alternative Medicines and Therapy Company Establishment Date
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global Alternative Medicines and Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Significant Companies of Oil Massage Therapy
Table 15. Significant Companies of Mud Therapy
Table 16. Significant Companies of Magnetic Therapy
Table 17. Global Alternative Medicines and Therapy Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 18. Global Alternative Medicines and Therapy Sales Value by Type (2021-2026) & (US$ Million)
Table 19. Global Alternative Medicines and Therapy Sales Value by Type (2027-2032) & (US$ Million)
Table 20. Global Alternative Medicines and Therapy Sales Value Share by Type (2021-2026)
Table 21. Global Alternative Medicines and Therapy Sales Value Share by Type (2027-2032)
Table 22. Significant Companies of Hospital
Table 23. Significant Companies of Clinic
Table 24. Global Alternative Medicines and Therapy Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 25. Global Alternative Medicines and Therapy Sales Value by Application (2021-2026) & (US$ Million)
Table 26. Global Alternative Medicines and Therapy Sales Value by Application (2027-2032) & (US$ Million)
Table 27. Global Alternative Medicines and Therapy Sales Value Share by Application (2021-2026)
Table 28. Global Alternative Medicines and Therapy Sales Value Share by Application (2027-2032)
Table 29. Global Alternative Medicines and Therapy Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 30. Global Alternative Medicines and Therapy Sales Value by Region (2021-2026) & (US$ Million)
Table 31. Global Alternative Medicines and Therapy Sales Value Share by Region (2021-2026)
Table 32. Global Alternative Medicines and Therapy Sales Value by Region (2027-2032) & (US$ Million)
Table 33. Global Alternative Medicines and Therapy Sales Value Share by Region (2027-2032)
Table 34. Global Alternative Medicines and Therapy Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 35. Global Alternative Medicines and Therapy Sales Value by Country (2021-2026) & (US$ Million)
Table 36. Global Alternative Medicines and Therapy Sales Value Market Share by Country (2021-2026)
Table 37. Global Alternative Medicines and Therapy Sales Value by Country (2027-2032) & (US$ Million)
Table 38. Global Alternative Medicines and Therapy Sales Value Market Share by Country (2027-2032)
Table 39. Allen Laboratories Ltd. Company Information
Table 40. Allen Laboratories Ltd. Business Overview
Table 41. Allen Laboratories Ltd. Alternative Medicines and Therapy Revenue (US$ Million) and Gross Margin (2021-2026)
Table 42. Allen Laboratories Ltd. Alternative Medicines and Therapy Product Portfolio
Table 43. Allen Laboratories Ltd. Recent Development
Table 44. Arya Vaidya Pharmacy Company Information
Table 45. Arya Vaidya Pharmacy Business Overview
Table 46. Arya Vaidya Pharmacy Alternative Medicines and Therapy Revenue (US$ Million) and Gross Margin (2021-2026)
Table 47. Arya Vaidya Pharmacy Alternative Medicines and Therapy Product Portfolio
Table 48. Arya Vaidya Pharmacy Recent Development
Table 49. Dr. Reddy’s Laboratories Ltd Company Information
Table 50. Dr. Reddy’s Laboratories Ltd Business Overview
Table 51. Dr. Reddy’s Laboratories Ltd Alternative Medicines and Therapy Revenue (US$ Million) and Gross Margin (2021-2026)
Table 52. Dr. Reddy’s Laboratories Ltd Alternative Medicines and Therapy Product Portfolio
Table 53. Dr. Reddy’s Laboratories Ltd Recent Development
Table 54. King Bio Pharmaceuticals Company Information
Table 55. King Bio Pharmaceuticals Business Overview
Table 56. King Bio Pharmaceuticals Alternative Medicines and Therapy Revenue (US$ Million) and Gross Margin (2021-2026)
Table 57. King Bio Pharmaceuticals Alternative Medicines and Therapy Product Portfolio
Table 58. King Bio Pharmaceuticals Recent Development
Table 59. Mediral International Company Information
Table 60. Mediral International Business Overview
Table 61. Mediral International Alternative Medicines and Therapy Revenue (US$ Million) and Gross Margin (2021-2026)
Table 62. Mediral International Alternative Medicines and Therapy Product Portfolio
Table 63. Mediral International Recent Development
Table 64. Sandoz International GmbH, Biocon Ltd. Company Information
Table 65. Sandoz International GmbH, Biocon Ltd. Business Overview
Table 66. Sandoz International GmbH, Biocon Ltd. Alternative Medicines and Therapy Revenue (US$ Million) and Gross Margin (2021-2026)
Table 67. Sandoz International GmbH, Biocon Ltd. Alternative Medicines and Therapy Product Portfolio
Table 68. Sandoz International GmbH, Biocon Ltd. Recent Development
Table 69. Sante Verte Ltd. Company Information
Table 70. Sante Verte Ltd. Business Overview
Table 71. Sante Verte Ltd. Alternative Medicines and Therapy Revenue (US$ Million) and Gross Margin (2021-2026)
Table 72. Sante Verte Ltd. Alternative Medicines and Therapy Product Portfolio
Table 73. Sante Verte Ltd. Recent Development
Table 74. Weleda Ltd., Cipla Ltd. Company Information
Table 75. Weleda Ltd., Cipla Ltd. Business Overview
Table 76. Weleda Ltd., Cipla Ltd. Alternative Medicines and Therapy Revenue (US$ Million) and Gross Margin (2021-2026)
Table 77. Weleda Ltd., Cipla Ltd. Alternative Medicines and Therapy Product Portfolio
Table 78. Weleda Ltd., Cipla Ltd. Recent Development
Table 79. Wright Health Group Ltd. Company Information
Table 80. Wright Health Group Ltd. Business Overview
Table 81. Wright Health Group Ltd. Alternative Medicines and Therapy Revenue (US$ Million) and Gross Margin (2021-2026)
Table 82. Wright Health Group Ltd. Alternative Medicines and Therapy Product Portfolio
Table 83. Wright Health Group Ltd. Recent Development
Table 84. Research Programs/Design for This Report
Table 85. Authors List of This Report
Table 86. Secondary Sources
Table 87. Primary Sources
List of Figures
Figure 1. Alternative Medicines and Therapy Product Image
Figure 2. Global Alternative Medicines and Therapy Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Alternative Medicines and Therapy Market Size (2021-2032) & (US$ Million)
Figure 4. Global Alternative Medicines and Therapy Company Revenue Ranking in 2025 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 7. Oil Massage Therapy Image
Figure 8. Mud Therapy Image
Figure 9. Magnetic Therapy Image
Figure 10. Global Alternative Medicines and Therapy Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 11. Global Alternative Medicines and Therapy Sales Value Share 2021 VS 2025 VS 2032
Figure 12. Global Alternative Medicines and Therapy Sales Value Share by Type (2021-2032)
Figure 13. Hospital Image
Figure 14. Clinic Image
Figure 15. Global Alternative Medicines and Therapy Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 16. Global Alternative Medicines and Therapy Sales Value Share 2021 VS 2025 VS 2032
Figure 17. Global Alternative Medicines and Therapy Sales Value Share by Application (2021-2032)
Figure 18. Global Alternative Medicines and Therapy Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 19. Global Alternative Medicines and Therapy Sales Value Share by Region: 2021 VS 2025 VS 2032
Figure 20. North America Alternative Medicines and Therapy Sales Value (2021-2032) & (US$ Million)
Figure 21. North America Alternative Medicines and Therapy Sales Value Share by Country (%), 2025 VS 2032
Figure 22. Europe Alternative Medicines and Therapy Sales Value (2021-2032) & (US$ Million)
Figure 23. Europe Alternative Medicines and Therapy Sales Value Share by Country (%), 2025 VS 2032
Figure 24. Asia-Pacific Alternative Medicines and Therapy Sales Value (2021-2032) & (US$ Million)
Figure 25. Asia-Pacific Alternative Medicines and Therapy Sales Value Share by Country (%), 2025 VS 2032
Figure 26. South America Alternative Medicines and Therapy Sales Value (2021-2032) & (US$ Million)
Figure 27. South America Alternative Medicines and Therapy Sales Value Share by Country (%), 2025 VS 2032
Figure 28. Middle East & Africa Alternative Medicines and Therapy Sales Value (2021-2032) & (US$ Million)
Figure 29. Middle East & Africa Alternative Medicines and Therapy Sales Value Share by Country (%), 2025 VS 2032
Figure 30. USA Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 31. USA Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 32. USA Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 33. Canada Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 34. Canada Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 35. Canada Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 36. Mexico Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 37. Mexico Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 38. Mexico Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 39. Germany Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 40. Germany Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 41. Germany Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 42. France Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 43. France Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 44. France Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 45. U.K. Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 46. U.K. Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 47. U.K. Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 48. Italy Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 49. Italy Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 50. Italy Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 51. Spain Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 52. Spain Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 53. Spain Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 54. Russia Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 55. Russia Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 56. Russia Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 57. Netherlands Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 58. Netherlands Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 59. Netherlands Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 60. Nordic Countries Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 61. Nordic Countries Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 62. Nordic Countries Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 63. China Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 64. China Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 65. China Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 66. Japan Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 67. Japan Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 68. Japan Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 69. South Korea Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 70. South Korea Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 71. South Korea Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 72. India Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 73. India Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 74. India Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 75. Australia Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 76. Australia Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 77. Australia Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 78. Southeast Asia Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 79. Southeast Asia Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 80. Southeast Asia Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 81. Brazil Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 82. Brazil Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 83. Brazil Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 84. Argentina Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 85. Argentina Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 86. Argentina Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 87. Chile Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 88. Chile Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 89. Chile Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 90. Colombia Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 91. Colombia Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 92. Colombia Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 93. Peru Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 94. Peru Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 95. Peru Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 96. Saudi Arabia Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 97. Saudi Arabia Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 98. Saudi Arabia Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 99. Israel Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 100. Israel Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 101. Israel Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 102. UAE Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 103. UAE Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 104. UAE Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 105. Turkey Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 106. Turkey Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 107. Turkey Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 108. Iran Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 109. Iran Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 110. Iran Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 111. Egypt Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 112. Egypt Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 113. Egypt Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 114. Years Considered
Figure 115. Research Process
Figure 116. Key Executives Interviewed
Scope & coverage.
Types
- Oil Massage Therapy
- Mud Therapy
- Magnetic Therapy
Applications
- Hospital
- Clinic
Companies covered
- Allen Laboratories Ltd.
- Arya Vaidya Pharmacy
- Dr. Reddy’s Laboratories Ltd
- King Bio Pharmaceuticals
- Mediral International
- Sandoz International GmbH, Biocon Ltd.
- Sante Verte Ltd.
- Weleda Ltd., Cipla Ltd.
- Wright Health Group Ltd.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Alternative Medicines and Therapy Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Alternative Medicines and Therapy Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Alternative Medicines and Therapy Market Dynamics
- 2.1 Alternative Medicines and Therapy Industry Trends
- 2.2 Alternative Medicines and Therapy Industry Drivers
- 2.3 Alternative Medicines and Therapy Industry Opportunities and Challenges
- 2.4 Alternative Medicines and Therapy Industry Restraints
3 Alternative Medicines and Therapy Market by Company
- 3.1 Global Alternative Medicines and Therapy Company Revenue Ranking in 2025
- 3.2 Global Alternative Medicines and Therapy Revenue by Company (2021-2026)
- 3.3 Global Alternative Medicines and Therapy Company Ranking (2024-2026)
- 3.4 Global Alternative Medicines and Therapy Company Manufacturing Base and Headquarters
- 3.5 Global Alternative Medicines and Therapy Company Product Type and Application
- 3.6 Global Alternative Medicines and Therapy Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Alternative Medicines and Therapy Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Alternative Medicines and Therapy Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Alternative Medicines and Therapy Market by Type
- 4.1 Alternative Medicines and Therapy Type Introduction
- 4.1.1 Oil Massage Therapy
- 4.1.2 Mud Therapy
- 4.1.3 Magnetic Therapy
- 4.2 Global Alternative Medicines and Therapy Sales Value by Type
- 4.2.1 Global Alternative Medicines and Therapy Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Alternative Medicines and Therapy Sales Value by Type (2021-2032)
- 4.2.3 Global Alternative Medicines and Therapy Sales Value Share by Type (2021-2032)
5 Alternative Medicines and Therapy Market by Application
- 5.1 Alternative Medicines and Therapy Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.2 Global Alternative Medicines and Therapy Sales Value by Application
- 5.2.1 Global Alternative Medicines and Therapy Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Alternative Medicines and Therapy Sales Value by Application (2021-2032)
- 5.2.3 Global Alternative Medicines and Therapy Sales Value Share by Application (2021-2032)
6 Alternative Medicines and Therapy Regional Value Analysis
- 6.1 Global Alternative Medicines and Therapy Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Alternative Medicines and Therapy Sales Value by Region (2021-2032)
- 6.2.1 Global Alternative Medicines and Therapy Sales Value by Region: 2021-2026
- 6.2.2 Global Alternative Medicines and Therapy Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Alternative Medicines and Therapy Sales Value (2021-2032)
- 6.3.2 North America Alternative Medicines and Therapy Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Alternative Medicines and Therapy Sales Value (2021-2032)
- 6.4.2 Europe Alternative Medicines and Therapy Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Alternative Medicines and Therapy Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Alternative Medicines and Therapy Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Alternative Medicines and Therapy Sales Value (2021-2032)
- 6.6.2 South America Alternative Medicines and Therapy Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Alternative Medicines and Therapy Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Alternative Medicines and Therapy Sales Value Share by Country, 2025 VS 2032
7 Alternative Medicines and Therapy Country-level Value Analysis
- 7.1 Global Alternative Medicines and Therapy Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Alternative Medicines and Therapy Sales Value by Country (2021-2032)
- 7.2.1 Global Alternative Medicines and Therapy Sales Value by Country (2021-2026)
- 7.2.2 Global Alternative Medicines and Therapy Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032)
- 7.7.2 France Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032)
- 7.14.2 China Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032)
- 7.17.2 India Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Alternative Medicines and Therapy Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Alternative Medicines and Therapy Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Alternative Medicines and Therapy Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Allen Laboratories Ltd.
- 8.1.1 Allen Laboratories Ltd. Company Information
- 8.1.2 Allen Laboratories Ltd. Business Overview
- 8.1.3 Allen Laboratories Ltd. Alternative Medicines and Therapy Revenue and Gross Margin (2021-2026)
- 8.1.4 Allen Laboratories Ltd. Alternative Medicines and Therapy Product Portfolio
- 8.1.5 Allen Laboratories Ltd. Recent Developments
- 8.2 Arya Vaidya Pharmacy
- 8.2.1 Arya Vaidya Pharmacy Company Information
- 8.2.2 Arya Vaidya Pharmacy Business Overview
- 8.2.3 Arya Vaidya Pharmacy Alternative Medicines and Therapy Revenue and Gross Margin (2021-2026)
- 8.2.4 Arya Vaidya Pharmacy Alternative Medicines and Therapy Product Portfolio
- 8.2.5 Arya Vaidya Pharmacy Recent Developments
- 8.3 Dr. Reddy’s Laboratories Ltd
- 8.3.1 Dr. Reddy’s Laboratories Ltd Company Information
- 8.3.2 Dr. Reddy’s Laboratories Ltd Business Overview
- 8.3.3 Dr. Reddy’s Laboratories Ltd Alternative Medicines and Therapy Revenue and Gross Margin (2021-2026)
- 8.3.4 Dr. Reddy’s Laboratories Ltd Alternative Medicines and Therapy Product Portfolio
- 8.3.5 Dr. Reddy’s Laboratories Ltd Recent Developments
- 8.4 King Bio Pharmaceuticals
- 8.4.1 King Bio Pharmaceuticals Company Information
- 8.4.2 King Bio Pharmaceuticals Business Overview
- 8.4.3 King Bio Pharmaceuticals Alternative Medicines and Therapy Revenue and Gross Margin (2021-2026)
- 8.4.4 King Bio Pharmaceuticals Alternative Medicines and Therapy Product Portfolio
- 8.4.5 King Bio Pharmaceuticals Recent Developments
- 8.5 Mediral International
- 8.5.1 Mediral International Company Information
- 8.5.2 Mediral International Business Overview
- 8.5.3 Mediral International Alternative Medicines and Therapy Revenue and Gross Margin (2021-2026)
- 8.5.4 Mediral International Alternative Medicines and Therapy Product Portfolio
- 8.5.5 Mediral International Recent Developments
- 8.6 Sandoz International GmbH, Biocon Ltd.
- 8.6.1 Sandoz International GmbH, Biocon Ltd. Company Information
- 8.6.2 Sandoz International GmbH, Biocon Ltd. Business Overview
- 8.6.3 Sandoz International GmbH, Biocon Ltd. Alternative Medicines and Therapy Revenue and Gross Margin (2021-2026)
- 8.6.4 Sandoz International GmbH, Biocon Ltd. Alternative Medicines and Therapy Product Portfolio
- 8.6.5 Sandoz International GmbH, Biocon Ltd. Recent Developments
- 8.7 Sante Verte Ltd.
- 8.7.1 Sante Verte Ltd. Company Information
- 8.7.2 Sante Verte Ltd. Business Overview
- 8.7.3 Sante Verte Ltd. Alternative Medicines and Therapy Revenue and Gross Margin (2021-2026)
- 8.7.4 Sante Verte Ltd. Alternative Medicines and Therapy Product Portfolio
- 8.7.5 Sante Verte Ltd. Recent Developments
- 8.8 Weleda Ltd., Cipla Ltd.
- 8.8.1 Weleda Ltd., Cipla Ltd. Company Information
- 8.8.2 Weleda Ltd., Cipla Ltd. Business Overview
- 8.8.3 Weleda Ltd., Cipla Ltd. Alternative Medicines and Therapy Revenue and Gross Margin (2021-2026)
- 8.8.4 Weleda Ltd., Cipla Ltd. Alternative Medicines and Therapy Product Portfolio
- 8.8.5 Weleda Ltd., Cipla Ltd. Recent Developments
- 8.9 Wright Health Group Ltd.
- 8.9.1 Wright Health Group Ltd. Company Information
- 8.9.2 Wright Health Group Ltd. Business Overview
- 8.9.3 Wright Health Group Ltd. Alternative Medicines and Therapy Revenue and Gross Margin (2021-2026)
- 8.9.4 Wright Health Group Ltd. Alternative Medicines and Therapy Product Portfolio
- 8.9.5 Wright Health Group Ltd. Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$4,250USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst